Valli Fiore Valter

Dr. Valter Valli Fiore

Operative Unit: Neurophysiology of Vision and Neurophthalmology Operating Unit

Sub-specialties: Pathologies of the optic nerve and of visual pathways

Clinical activity: He works at the IRCCS "G.B. Bietti ", “Britannico” Hospital, Via di Santo Stefano Rotondo 6, 00184 Rome (third floor,  rooms 37-38)


Education

2000: High school diploma, "G.Vallauri ", Rome.
2006: Bachelor Degree with Honors in Dagnostic Tecniques of Neurophysiology  at the University of  Study “Tor Vergata”
in Rome.
2003-2006: Attendance at the Department of Neurophysiophatology at  Universitary Hospital "Policlinico Tor Vergata "of Rome

Roles

  • 2007 al 2008: Fellow as Technician of Neurophysiology and clinical researcher at the Neurophysiology of Vision and Neurophthalmology Research Unit, IRCCS "G.B." Bietti Foundation, Rome.
  • 2009-2016: Contractor as Technician of Neurophysiology and clinical researcher at the Neurophysiology of Vision and Neurophthalmology Research Unit, IRCCS "G.B." Bietti Foundation, Rome.
  • 2017-current: Full time position  as Technician of Neurophysiology and clinical researcher at the Neurophysiology of Vision and Neurophthalmology Research Unit, IRCCS "G.B." Bietti Foundation, Rome.
  • 2014-2017:
    Institutional  Ministerial Project:
    Morphofunctional visual pathways evaluation in multiple sclerosis: possible identification of neurodegenerative biomarkers. Project Code: RF-2011-02347280. Principal Investigator: Prof. Vincenzo Parisi
  • 2016:
    No profit clinical study (Bietti Foundation - IRCCS NEU-03-2016)
    Neuroprotection and neuroprotentation in a model of optic nerve neurodegeneration (non-arteritic ischemic optic neuritis): study of morpho-functional variations in relation to treatment with citicoline in oral solution. Principal Investigator: Prof. Vincenzo Parisi
  • 2016:
    Clinical observational study (5x1000 funds of the Ministry of Health, year 2013,  promoted by Bietti Foundation - IRCCS NEU-03-2016)
    Functional evaluation of retinal involvement in post-neuritic neurodegenerative processes in patients with multiple sclerosis. Principal Investigator: Prof. Vincenzo Parisi and Dr. Lucia Ziccardi
  • 2016:
    Observational study SNT-CRS-002 promoted by Santhera Pharmaceuticals
    Historical case record of visual acuity from patients with Leber's Hereditary Optic Neuropathy (LHON). Principal Investigator: Prof. Vincenzo Parisi
  • 2014-2015:
    Clinical study (5x1000 funds of the Ministry of Health, year 2011, promoted by Bietti Foundation - IRCCS NEU-01-2014)
    "Clinical and functional characterization of ocular rare diseases with genetic transmission. Phenotype-genotype correlation “ Principal Investigator: Prof. Vincenzo Parisi and Dr. Lucia Ziccardi
  • 2011:
    AIFA (Italian Agency for Drugs) clinical study (promoted by Bietti Foundation - IRCCS NEU-08-2011)
    Evaluation of the neuroprotective activity of Minocycline as adjuvant therapy for stabilization of visual function in patients with glaucoma. Principal Investigator: Prof. Vincenzo Parisi.
  • 2013: Clinical sponsored study (DOMPE 'NGF0113 ")
    “A phase Ib / II, multicenter, randomized, double-masked, vehicle controlled, parallel group, dose ranging study with a 24 week follow-up period to evaluate the safety and potential efficacy of two doses (60 and 180 μg / ml) of recombinant human nerve growth factor (rhNGF) eye drops solution versus vehicle in patients with typical retinitis pigmentosa (RP) ". The study involves the administration of rhNGF eye drops (recombinant human nerve growth factor) in patients suffering from an orphan disease called cures called retinitis pigmentosa. Principal Investigator: Prof. Vincenzo Parisi.
  • 2013: LHON Historical Case Record Survey promoted by AIBILI (EVICr.net). Principal Investigator: Prof. Vincenzo Parisi
  • 2012-2013: Sponsored Study (SIGMA TAU ST200-ODU-09-01)
    "Effects of administration of L-acetylcarnitine on nerve conduction along the optical pathways in patients suffering from Leber neurotropopathy (Leber Hereditary Optic Neuropathy)". The study involves the oral administration of an experimental drug L-acetylcarnitine in patients with genetically proven hereditary optic neuropathy. Principal Investigator: Prof. Vincenzo Parisi.
  • 2012: No profit clinical study (promoted by Bietti Foundation - IRCCS NEU-01-2012)
  • “Evaluation of the potential neuroprotective action of Citicoline in addition to the hypotonic topical therapy for the maintenance and / or improvement of visual functional deficit in patients with glaucoma”. Principal Investigator: Prof. Vincenzo Parisi.